Post-COVID pulmonary fibrosis, which involves scarring of the lungs that can worsen over time and may require a lung ...

The study in the European Respiratory Journal used advanced spatial mapping techniques to compare healthy lung tissues and tissues from patients with fatal IPF. The researchers discovered that disease ...

This progressive lung disease transforms healthy tissue into stiff, scarred areas making breathing difficult. Learn the ...

Rutgers Health researchers have discovered that networks of misplaced immune cells drive an aggressive lung disease, ...

Discover how Temple Lung Center’s innovative clinical trials provide early access to breakthrough treatments and enhanced ...

Idiopathic pulmonary fibrosis (IPF) scars lung tissue and makes breathing increasingly difficult until patients can't get enough oxygen. Available drugs provide minimal benefit. Lung ...

Rutgers Health researchers have discovered that networks of misplaced immune cells drive an aggressive lung disease, potentially opening a path to new treatments for a condition that kills 80% of ...

When the scarring is in the tissues of the lung, these are called “sequelae” or fibrotic changes, which can lead to loss of lung function. The loss of lung function can manifest with shortness ...

One of those included a condition known as post-COVID pulmonary fibrosis, which involves scarring of the lungs that can worsen over time and may require a lung transplant, according to pulmonologists.